Recombinant Human MUC17 Protein，His

MUC17 is a member of the mucin family of glycoproteins, which are characterized by their high glycosylation and large size, playing crucial roles in protective mucosal barriers in various tissues, particularly in the gastrointestinal tract. Research on MUC17 has garnered attention due to its involvement in various physiological and pathological processes, including inflammation and cancer progression. Specifically, MUC17 is expressed in epithelial cells, where it contributes to the formation of the protective mucous layer, thus playing a vital role in maintaining mucosal integrity. Its expression patterns have been observed to change in several diseases, including colorectal cancer, where it may facilitate tumor progression and metastasis. The interest in MUC17 as a therapeutic target has prompted studies aimed at understanding its structural and functional properties, which can aid in the development of diagnostic markers or potential therapeutic strategies. Recombinant MUC17 protein production has emerged as a vital tool in this research, enabling scientists to study its interactions with other molecules, assess its role in cell signaling, and explore its potential in immunotherapy. By elucidating the mechanisms through which MUC17 operates, researchers hope to uncover novel insights into disease mechanisms and identify new avenues for treatment in mucosal-associated conditions.